ATE412661T1 - Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält - Google Patents

Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält

Info

Publication number
ATE412661T1
ATE412661T1 AT04746555T AT04746555T ATE412661T1 AT E412661 T1 ATE412661 T1 AT E412661T1 AT 04746555 T AT04746555 T AT 04746555T AT 04746555 T AT04746555 T AT 04746555T AT E412661 T1 ATE412661 T1 AT E412661T1
Authority
AT
Austria
Prior art keywords
peptide
producing
pharmaceutical composition
composition containing
new
Prior art date
Application number
AT04746555T
Other languages
English (en)
Inventor
Henry Aoki
Original Assignee
Kuboyama Bioken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuboyama Bioken Co Ltd filed Critical Kuboyama Bioken Co Ltd
Application granted granted Critical
Publication of ATE412661T1 publication Critical patent/ATE412661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Tea And Coffee (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04746555T 2003-12-29 2004-06-22 Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält ATE412661T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/747,466 US7390874B2 (en) 2003-12-29 2003-12-29 Peptide, method of production thereof, and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
ATE412661T1 true ATE412661T1 (de) 2008-11-15

Family

ID=34700745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04746555T ATE412661T1 (de) 2003-12-29 2004-06-22 Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält

Country Status (9)

Country Link
US (1) US7390874B2 (de)
EP (1) EP1710251B1 (de)
JP (1) JP4516026B2 (de)
KR (1) KR101132077B1 (de)
CN (1) CN1902217B (de)
AT (1) ATE412661T1 (de)
DE (1) DE602004017512D1 (de)
ES (1) ES2317005T3 (de)
WO (1) WO2005066200A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261197A1 (en) * 2004-05-19 2005-11-24 Henry Aoki Coffee bean extract, method of extraction and composition containing the same
US20070235217A1 (en) * 2006-03-29 2007-10-11 Workman Derek B Devices with microjetted polymer standoffs
CN1879727B (zh) * 2006-05-09 2010-04-21 中国科学院上海药物研究所 新型抗乙肝病毒抑制剂及其应用
US20110009345A1 (en) * 2009-07-08 2011-01-13 Henry Aoki Food ingredient comprising functional peptide
US20110056823A1 (en) * 2009-09-04 2011-03-10 Henry Aoki Methods and apparatus for extracting active ingredients
US10005816B2 (en) * 2014-12-15 2018-06-26 The Folger Coffee Company Peptides and their use in food and beverage
CN109042953B (zh) * 2018-09-12 2024-07-02 中国农业科学院茶叶研究所 一种茶叶炒干机
CN112521442B (zh) * 2020-12-21 2023-04-28 吕梁学院 一种活性肽萃取装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4776104A (en) * 1987-04-27 1988-10-11 Kuboyama Nobuyoshi Balanced extraction system
JPH07100008B2 (ja) 1988-06-27 1995-11-01 長谷川香科株式会社 天然苦味物質の製造法
JPH0391456A (ja) 1989-09-01 1991-04-17 Kikkoman Corp 香気成分の濃縮法
US5170697A (en) 1991-11-12 1992-12-15 Nobuyoshi Kuboyama Extraction apparatus, process and product produced thereby
US5572923A (en) 1995-06-26 1996-11-12 Kuboyama; Nobuyoshi Health beverage that an extracted ingredient from plant, animal or mineral is major ingredient, and manufacturing method and apparatus therefor
US5558006A (en) 1994-08-04 1996-09-24 Kuboyama; Nobuyoshi Health beverage plant extraction apparatus
GB2293776B (en) * 1994-08-04 1996-09-04 Nobuyoshi Kuboyama Health beverage with an extracted ingredient from plant, animal or mineral as major ingredient, and manufacturing method and apparatus therefor
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US5960563A (en) 1998-01-12 1999-10-05 Big Beans Holding, Ltd. Extraction and drying apparatus
CA2296966A1 (en) 1999-03-04 2000-09-04 Aoki Corporation Extraction apparatus and method
JP2004514741A (ja) 2000-12-06 2004-05-20 ライルズ，　マーク　ビー． ポリヌクレオチドインターカレーターインターセプターおよびインヒビター

Also Published As

Publication number Publication date
EP1710251A4 (de) 2007-10-24
JPWO2005066200A1 (ja) 2007-12-20
EP1710251B1 (de) 2008-10-29
JP4516026B2 (ja) 2010-08-04
CN1902217A (zh) 2007-01-24
EP1710251A1 (de) 2006-10-11
KR20060128931A (ko) 2006-12-14
CN1902217B (zh) 2010-05-05
ES2317005T3 (es) 2009-04-16
WO2005066200A1 (ja) 2005-07-21
US7390874B2 (en) 2008-06-24
US20050143313A1 (en) 2005-06-30
DE602004017512D1 (de) 2008-12-11
KR101132077B1 (ko) 2012-04-02

Similar Documents

Publication Publication Date Title
GEP20084487B (en) Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
DE69627035D1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
ATE361924T1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60222248D1 (de) Aminomethylgruppen enthaltende n-(arylsulfonyl)beta-aminosäure-derivate, verfahren zu deren herstellung sowie deren pharmazeutische zubereitungen
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69733272D1 (de) N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta-amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen
ATE235507T1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE472548T1 (de) Substituierte hexahydro-pyrazino(1,2-a)pyrimidin- 4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50304569D1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
EP1089968A4 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE412661T1 (de) Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
DE59909917D1 (de) Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
WO2004046096A3 (en) Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
ATE203665T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
ATE353321T1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
ATE331027T1 (de) Massgeschneiderte peptidsynthetasen, verfahren zu ihrer herstellung und ihre verwendung
WO2006010084A3 (en) A system for delivering therapeutic agents into living cells and cell nuclei
DE50301507D1 (de) 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
DE60007168D1 (de) Benzopyranyl-guanidin-derivate, verfahren zu deren herstellung sowie diese enthaltenden pharmazeutische zusammensetzungen
ATE323097T1 (de) Neue 5-thio-ss-d-xylopyranosidderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und deren therapeutische verwendung
ATE484516T1 (de) 3.beta.,28-diacetoxy-18-oxo-19,20,21,29,30- pentanorlupan-22-säure solvate, verfahren zu ihrer herstellung und pharmazeutische präparate daraus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties